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Streptomycin and aminoglycoside derivatives are commonly used to treat tuberculosis and other 
stubborn infections; these drugs may alter auditory and/or vestibular function. Mutations in mito-
chondrial DNA have been associated with hypersensitivity to aminoglycosides; no studies have been 
conducted in Mexicans, which are very prone to such alterations because aminoglycosides have 
been prescribed carelessly for many years, irrespective of the ailment to be treated. 
Aim: We investigated “hot spot” mutations described previously as causing inner ear alterations. 
Methods: Hot spot mutations at the 12S rRNA gene and the tRNA Serine (UCN) gene were screened 
by PCR-RFLP and sequencing in 65 subjects undergoing audiological and vestibular testing. 
Study Design: Experimental. 
Results: 32 individuals had healthy auditory and vestibular function, whereas 33 subjects had au-
ditory affections. We found none of the previously reported mutations related to aminoglycoside 
hypersensitivity, or non-syndromic hearing loss. Two hearing-impaired patients that had been treated 
with streptomycin had the T1189C variant of the mitochondrial 12S rRNA region. 
Conclusion: Mutations related to hearing loss in other ethnic backgrounds were not found in 
Mexicans. However, the T1189C variant is possibly a putative mutation related to aminoglycoside 
hypersensitivity and was present in 2 patients.
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INTRODUCTION 
Deafness is one of the main diseases among the 
human world population. In Mexico, 5 of every 1,000 
neonates are born deaf, contrasting with 1 of 1,000 deaf 
newborn children worldwide1. Among the former, 25% are 
genetically determined, 25% have a non-genetic origin, and 
the etiology is unknown in the remaining 50%. Deafness 
may be syndromic when one or more systems besides 
the auditory apparatus are affected; in non-syndromic 
hypoacusia, only the auditory system is affected (pure 
deafness). Non-syndromic hypoacusia is frequently in-
herited from the mother, indicating that genetic changes 
occur in mitochondrial DNA (mtDNA). Inner ear structures 
are very sensitive to injury because of their specific physi-
ologic energy requirements (ion carriers and channels)2. 
A silent sudden and dangerous cause of non-syndromic 
deafness occurs when mtDNA confers a high sensitivity 
to aminoglycosides (streptomycin family); these drugs are 
often used in the treatment of stubborn infections, such as 
Tuberculosis, which do not respond to others antibiotics3.
Aminoglycosides affect mainly molecules involved 
in protein synthesis; they inhibit protein synthesis initia-
tion by interacting with the site where the anticodon tRNA 
region (usually tRNA methionine) meets the A site of 
ribosomal RNA. This mechanism has been elucidated in 
bacterial 16S rRNA, and probably occurs in mitochondrial 
12S rRNA4,5.
The non-syndromic deafness-associated 12S rRNA 
region has been studied in several ethnic groups, and 
putative mutations have been described6,7, namely: 
T961insC, T961C and T961+C(n)ins in Chinese patients8 
and Italian families9; T1095C and C1494T in Chinese10, 
Spanish11 patients and Spanish families12; and A1555G in 
Korean patients13 and Japanese14, Chinese15, and Italian 
families16. The tRNA Serine(UCN) A7445G mutation gene has 
also been related with non-syndromic-deafness17 has also 
been investigated.
Mitochondrial DNA is transmitted by the mother; 
its polymorphisms (also named “variants”), when present 
in certain sites, seem to increase the risk or susceptibility 
to develop certain neurodegenerative conditions such as 
hearing loss18.
Because aminoglycoside are used frequently (it is 
the treatment of choice for tuberculosis), we decided to 
investigate three different changes or hot spot mutations at 
the 3´ end of the 12S rRNA region (T961+C(n)ins, A1555G, 
and C1494T), and tRNA Serine(UCN) (A7445G) of mitochon-
drial DNA that could be associated with aminoglycoside 
hypersensitivity in patients previously screened for healthy 
or compromised auditory and/or vestibular function.
MATERIALS AND METHODS
Subjects
The study sample comprised 65 Mexican subjects 
selected at the Instituto Nacional de Enfermedades Res-
piratorias, Mexico, who agreed to participate (Protocol 
B04-02). The clinical history was taken, focusing on past 
aminoglycoside treatments. Vestibular and auditory func-
tion was investigated in all selected individuals Peripheral 
blood samples were taken for DNA extraction (DNAzol-
Invitrogen, technique provided by the suppliers) and 
screened for the presence of hot spot mitochondrial DNA 
mutations related to non-syndromic-deafness.
Audiological and vestibular evaluation
The age of individuals ranged from 5 to 70 years 
(mean - 35 years). Otoscopy and pure tone audiometry at 
thresholds of 25, 250, 500, 1000, 2000, 4000, and 8000 Hz 
(Interacustic AC 40 audiometer) were carried out. Hearing 
above 25 dB was considered normal; hearing loss was mild 
(25 to 40 dB), moderate (45 to 60 dB), severe (65 to 80 
dB), and profound (85 to 120 dB). Caloric tests were also 
run in all individuals to assess vestibular damage. 
Polymerase chain reaction-restriction fragment length 
polymorphism (PCR-RFLP)
The technique was performed as in Hutchin T, et 
al for A1555G19 for 961 site mutations (324-349 and 1282-
1307, Mnl), and A7445G (7399-7419 and 7751-7771, Xba 
I). The procedure consisted of denaturation at 95°C for 
5 min, followed by 35 cycles (95°C for 20s, 50°C for 30 
s, and 72°C for 30 s), and a final extension at 72°C for 7 
min. Each PCR fragment was digested by enzymatic restric-
tion with the abovementioned enzymes and separated by 
electrophoresis in agarose 3%. 
For the C1494T mutation and other variants around 
the A1555G region, PCR amplification was done using the 
Phusion DNA polymerase (New England Biolabs) and 
oligonucleotides corresponding to the positions 1011-1134 
and 1624-1644. The PCR conditions were: denaturation at 
98°C for 5 min, followed by 35 cycles (98°C for 30s, 60°C 
for 30 s, and 72°C for 45s), and a final extension at 72°C 
for 5 min. Each fragment was column purified (Quiagen) 
and each sample was subsequently analyzed twice by 
direct bidirectional sequencing in an ABI PRISM 310 Ge-
netic Analyzer Perkin-Elmer Applied Biosystems. The se-
quence alignment was performed with BLAST and DNAstar 
programs and compared with the consensus Cambridge 
sequence (GenBank Accession No. NC_012920), Human 
Mitochondrial Genome Database. Chromatograms were 
all manually checked for sequence analysis.
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The sequences of the following species were used 
for alignment to search for conservation of the sites where 
the variants were located in the 12S rRNA gene: human 
(NC_012920), cow (NC_006853), dog (NC_002008), rat 
(NC_001665), chimp (NC_001643), gorilla (NC_001645) 
and mouse (NC_005089).
RESULTS
Clinical findings
Among the 65 study subjects, audiological and ves-
tibular evaluation revealed that 32 had healthy auditory and 
vestibular function, whereas the remaining 33 presented 
hearing loss (Figure 1). Of these latter, 18 patients had 
profound hearing loss, 14 had mild hearing loss, and only 
13 had vestibular damage. Aminoglycoside therapy had 
been given to 15 subjects; 18 subjects were not treated.
DISCUSSION
The 12S rRNA region in mitochondrial DNA has 
been described as a hot spot for nucleotide variability 
related with non-syndromic deafness as a result of amino-
glycoside hypersensitivity; several reports have confirmed 
this finding. In our molecular biological studies, we found 
no mutation associated with hearing loss and aminogly-
coside hypersensitivity.
However, we found a T to C change in the position 
1189 in two patients, irrespective of alignment with the 
universal Cambridge database, which is the first report 
in the literature (to our knowledge) of such a nucleotide 
sequence change in the region close to the 3´end of the 
mitochondrial 12S rRNA gene, which could be correlated 
with auditory or vestibular alterations due to aminogly-
cosides (Figure 2A).
Figure 1. Audiograms - analysis of the 12S rRNA gene - Audiograms of 
subjects analyzed in the 12S rRNA gene. (A) Healthy individual without 
audiometric alterations and (B) Patient with hearing loss.
PCR-RFLP and sequences analysis
When the reported sites (961 insCn, C1494T, 
A1555G, and A7445G) were screened, they were not found 
in any of the samples of the study groups. However, we 
found a change (thymidine to cytosine) at the 1189 site in 
the 12S rRNA gene of 2 patients with auditory and vestibu-
lar diseases, who had been treated with streptomycin (one 
of them had been treated additionally with kanamicyn).
Figure 2. T1189C in 12S rRNA - (A) Partial chromatogram sequences 
of the 12S rRNA gene in T1189C carriers, and (B) Partial sequence 
alignment of the 12S rRNA gene in different species showing that the 
position 1189 is highly conserved.
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Analysis of the position 1189 in different species 
has shown that it is a highly conserved site (Figure 2B). 
Whether or not it is a result of aminoglycoside hypersen-
sitivity in patient would have to be investigated in a larger 
series. The T1189C variant is in the region where C1494T 
and A1555G changes have been found; their action may 
be attributed to closeness to the ribosome site A where 
protein synthesis is initiated.
CONCLUSION
Our results suggest that mutations associated with 
hearing loss and aminoglycoside toxicity, which are found 
in other ethnic groups, were not present in Mexicans. 
Furthermore, the T1189C variant, which had not been 
previously reported, is apparently associated with ami-
noglycoside treatment. Whether this putative mutation is 
present in other individuals is of significant importance, 
as it may be a valuable screening marker prior to therapy. 
Recommendations may be given to avoid damage due to 
these hazardous antibiotics.
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